386 476
References
[1]
Song Z, Colla CH. Specialty-based global payment. Jama 2016;315:2271.[2]
Khuri SF, Daley J, Henderson W, et al. The Department of Veterans Affairs’ NSQIP- the first national, validated, outcome-based, risk- adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. Ann Surg 1998;228: 491–507.
[3]
Spencer BA, Miller DC, Litwin MS, et al. Variations in quality of care for men with early-stage prostate cancer. J Clin Oncol 2008;26:3735–42.[4]
McGory ML, Shekelle PG, Ko CY. Development of quality indicators for patients undergoing colorectal cancer surgery. J Natl Cancer Inst 2006;98:1623–33.[5]
Schroeck FR, Kaufman SR, Jacobs BL, et al. Adherence to perfor- mance measures and outcomes among men treated for prostate cancer. J Urol 2014;192:743–8.[6]
Hibbard JH, Stockard J, Tusler M. Hospital performance reports: impact on quality, market share, and reputation. Health Affairs 2005;24:1150–60.[7]
Birkmeyer JD, Dimick JB, Birkmeyer NJO. Measuring the quality of surgical care: structure, process, or outcomes? J Am Coll Surg 2004;198:626–32.[8]
Wood L, Bjarnason GA, Black PC, et al. Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma. J Oncol Pract 2013;9:e262–7.[9]
Henneman D, van Bommel AC, Snijders A, et al. Ranking and rankability of hospital postoperative mortality rates in colorectal cancer surgery. Ann Surg 2014;259:844–9.
[10]
Massarweh NN, Hu CY, You YN, et al. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. J Clin Oncol 2014;32:2967–74.[11]
Tsai TC, Joynt KE, Orav EJ, et al. Variation in surgical-readmission rates and quality of hospital care. N Engl J Med 2013;369: 1134–42.[12]
Russell MC, You YN, Hu CY, et al. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg 2013;148:769–77.
[13]
Merlo J. A brief conceptual tutorial of multilevel analysis in social epidemiology: using measures of clustering in multilevel logistic regression to investigate contextual phenomena. J Epidemiol Com- munity Health 2006;60:290–7.[14]
Shahian DM, Normand SLT. Comparison of ‘‘risk-adjusted’’ hospital outcomes. Circulation 2008;117:1955–63.[15]
Jones HE, Ohlssen DI, Spiegelhalter DJ. Use of the false discovery rate when comparing multiple health care providers. J Clin Epide- miol 2008;61:232–40.
[16]
Spiegelhalter DJ. Funnel plots for comparing institutional perfor- mance. Stat Med 2005;24:1185–202.
[17]
Gore JL, Wright JL, Daratha KB, et al. Hospital-level variation in the quality of urologic cancer surgery. Cancer 2012;118:987–96.
[18]
Kiechle JE, Abouassaly R, Gross CP, et al. Racial disparities in partial nephrectomy persist across hospital types: results from a popula- tion-based cohort. Urology 2016;90:69–74.
[19]
Kim SP, Shah ND, Weight CJ, et al. Contemporary trends in nephrec- tomy for renal cell carcinoma in the united states: results from a population based cohort. J Urol 2011;186:1779–85.
[20]
Donabedian A. The quality of medical care. Science 1978;200: 865–74.[21]
Dimick JB, Staiger DO, Osborne NH, et al. Composite measures for rating hospital quality with major surgery. Health Serv Res 2012;47:1861–79.[22]
Maurice MJ, Zhu H, Kiechle JE, et al. Increasing biopsy utilization for renal cell carcinoma is closely associated with treatment. Urology 2015;86:906–13.
E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 3 7 9 – 3 8 6
386